Additional file 1: Fig. 1s: Changes of BMI percentile in JDM patients over study duration (60 months). T0 represented baseline date (before initiation of treatment), note data available for around 53% of the study subject. Other time point are T1 > 1.5 years, T2 = 1.51–3.49 years, and T3 = 3.5–5 years. The BMI percentile was calculated based on CDC published charts ( https://www.cdc.gov/growthcharts/clinical_charts.htm ). Overweight was defined as a BMI at or above the 85th percentile and below the 95th percentile for age and gender-matched children. Obesity was defined as a BMI at or above the 95th percentile for age and gender-matched children and divided into two groups based on severity
The scatter plots of source data for correlational analysis presented in Table 3. Changes between fi...
Figure S1. Flow-chart of participants included in the longitudinal analysis. Figure S2. Proportion o...
Table S1. Physical activity characteristics measured by accelerometry before lifestyle intervention ...
Additional file 2: Fig. 2s: Changes of Total body fat (TBF) percentile in JDM patients over study du...
Additional file 3: Fig. 3s: Correlation between Total body fat (TBF) percentile at the last visit (T...
Additional file 4: Fig. 4s: Correlation between Total body fat (TBF) percentile at the last visit (T...
Detailed information on patterns in the use of high-dose glucocorticoid therapy in moderate juvenile...
Detailed information on patterns in the use of intravenous methylprednisolone pulse (IVMP) therapy i...
Disease Characteristics of 45 Patients with Juvenile Dermatomyositis. (DOCX 27 kb
Table S1. BoxâCox values for power (L), adjusted mean (M), and coefficient of variation (S) of WC ...
Juvenile dermatomyositis (JDM) is an autoimmune disease that affects children with muscle inflammati...
CARRA survey: Use of Biologics in Juvenile Dermatomyositis. Appendix B Second CARRA JDM Survey: Use ...
To study growth and puberty in a multinational longitudinal prospective cohort of children with juve...
Objective: To analyse bone mineral density (BMD) in juvenile dermatomyositis (JDM) and its possible ...
Table S1. Lipid profiles in serum from patients with PM/DM and healthy individuals. Table S2. Lipid ...
The scatter plots of source data for correlational analysis presented in Table 3. Changes between fi...
Figure S1. Flow-chart of participants included in the longitudinal analysis. Figure S2. Proportion o...
Table S1. Physical activity characteristics measured by accelerometry before lifestyle intervention ...
Additional file 2: Fig. 2s: Changes of Total body fat (TBF) percentile in JDM patients over study du...
Additional file 3: Fig. 3s: Correlation between Total body fat (TBF) percentile at the last visit (T...
Additional file 4: Fig. 4s: Correlation between Total body fat (TBF) percentile at the last visit (T...
Detailed information on patterns in the use of high-dose glucocorticoid therapy in moderate juvenile...
Detailed information on patterns in the use of intravenous methylprednisolone pulse (IVMP) therapy i...
Disease Characteristics of 45 Patients with Juvenile Dermatomyositis. (DOCX 27 kb
Table S1. BoxâCox values for power (L), adjusted mean (M), and coefficient of variation (S) of WC ...
Juvenile dermatomyositis (JDM) is an autoimmune disease that affects children with muscle inflammati...
CARRA survey: Use of Biologics in Juvenile Dermatomyositis. Appendix B Second CARRA JDM Survey: Use ...
To study growth and puberty in a multinational longitudinal prospective cohort of children with juve...
Objective: To analyse bone mineral density (BMD) in juvenile dermatomyositis (JDM) and its possible ...
Table S1. Lipid profiles in serum from patients with PM/DM and healthy individuals. Table S2. Lipid ...
The scatter plots of source data for correlational analysis presented in Table 3. Changes between fi...
Figure S1. Flow-chart of participants included in the longitudinal analysis. Figure S2. Proportion o...
Table S1. Physical activity characteristics measured by accelerometry before lifestyle intervention ...